Tag: #Global Trends

Regeneron Pharmaceuticals has finalized a comprehensive research and development collaboration valued at $2.32 billion with Parabilis Medicines. The joint initiative... Read more

An investigational therapeutic agent acquired by BioMarin Pharmaceutical via a corporate buyout has failed to meet one of its two... Read more

Privately held biopharmaceutical firm Mentari Therapeutics has unveiled plans to transition into the public equity markets through a definitive reverse... Read more

An investigational drug candidate developed by Relay Therapeutics has demonstrated encouraging efficacy signals in a mid-stage clinical trial, presenting a... Read more

A federal jury in Boston has delivered a milestone antitrust verdict against Takeda, finding the Japanese drugmaker liable for conspiring... Read more

Framework of the Voluntary Licensing Agreement Swiss pharmaceutical corporation Roche has executed a voluntary licensing agreement with the Medicines Patent... Read more

Strategic Framework and Jurisdictions AstraZeneca and Roche Diagnostics Asia Pacific have finalized a landmark three-year Memorandum of Understanding (MOU) to... Read more

Financial Performance and Incretin Portfolio Dominance Eli Lilly has reported its financial results for the first quarter of 2026, with... Read more

Overview and Objectives of the Alliance California-based Dark Horse Consulting Group and Beijing-based clinical research organization (CRO) KunTuo Research and... Read more